Premium
Localization of platelet‐derived growth factor receptor subunit expression in chronic venous leg ulcers
Author(s) -
Peus Dominik,
Jungtäubl Helmut,
Knaub Sigurd,
Leuker Andreas,
Gerecht Klaus,
Ostendorf Rolf,
MeyerIngold Wolfgang,
Wlaschek Meinhard,
Krieg Thomas,
Ruzicka Thomas,
ScharffetterKochanek Karin
Publication year - 1995
Publication title -
wound repair and regeneration
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.847
H-Index - 109
eISSN - 1524-475X
pISSN - 1067-1927
DOI - 10.1046/j.1524-475x.1995.30306.x
Subject(s) - wound healing , platelet derived growth factor , growth factor , growth factor receptor , receptor , platelet , fibroblast growth factor , vascular endothelial growth factor , granulation tissue , biology , growth factor receptor inhibitor , platelet derived growth factor receptor , cancer research , immunology , medicine , vegf receptors
Cellular responses to platelet‐derived growth factor, which affects all phases of the wound healing process, are dependent on the interaction of the growth factor with its cell surface receptors. Recently, we have shown that the platelet‐derived growth factor‐receptor was not expressed in uninjured human skin. In acute human wounds healing by secondary intention, both platelet‐derived growth factor‐receptor subunits were coordinately expressed, whereas no expression was found after reepithelialization at day 47. Even though impaired wound healing may be due to uncoordinated expression or the failure to express platelet‐derived growth factor‐receptor subunits, little is known regarding their expression in chronic ulcers. We studied the localization of platelet‐derived growth factor‐receptor expression in chronic venous leg ulcers of 15 patients with a median age of 73 years. Cryostat sections of biopsy specimens were immunostained with the use of antibodies against the α‐ and the β‐platelet‐derived growth factor subunits. RNA was extracted from biopsy specimens and subjected to Northern blot analysis with the use of oligolabeled complementary DNA for the platelet‐derived growth factor‐receptor. Platelet‐derived growth factor‐receptor α‐ and β‐subunit expression was found in fibroblast‐like cells within the wound bed and in cells beneath the epidermis of the wound edge. Platelet‐derived growth factor‐receptor β‐subunit expression was detected in endothelial cells of the vessels, in the granulation tissue, and the wound edge, whereas platelet‐derived growth factor‐receptor α‐subunit was not expressed in endothelial cells of the uninjured skin. This finding suggests that the platelet‐derived growth factor α‐subunit may be involved in vessel formation during tissue repair. Both platelet‐derived growth factor‐receptor subunits were expressed at the messenger RNA level indicating that the synthesis is at least partly regulated at a pretranslational level. As the cellular responsiveness to growth factors depends on their specific receptors, our finding that both platelet‐derived growth factor‐receptor subunits are expressed in chronic venous ulcers substantiates the concept of therapeutic trials with recombinant platelet‐derived growth factor.